Global OTC Drug Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 96
Inquire Before Buying

Non-prescription drugs refer to drugs that can be purchased for The convenience of The public without a prescription from a physician or other medical professional. The general public can use The drugs on their own discretion according to The drug labels and instructions.

The global OTC Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for OTC Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding OTC Drug.

Report Scope

The OTC Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global OTC Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The OTC Drug companies, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Bayer HealthCare

- GlaxoSmithKline(GSK)

- Johnson&Johnson

- Pfizer

- Sanofi

- AstraZeneca

- BioGaia

- Bristol Myers Squibb

- Bukwang Pharmaceutica

- Chr. Hansen

- Cipla

- CoLucid

- Daiichi Sankyo

- Friggs

- DSM

- Eisai

- Eli Lilly

- Herbalife

- Euradite

Segment by Type

- Class A OTC Drug

- Class B OTC Drug

Segment by Application

- Hospital

- Clinic

- Household

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by companies in The industry, and The analysis of relevant policies in The industry.

Chapter 3: Detailed analysis of OTC Drug companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa Segment by country. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and capacity of each country in The world.

Chapter 11: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of The report.

Global OTC Drug Market Research Report 2024

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Class A OTC Drug
1.2.3 Class B OTC Drug
1.3 Market by Application
1.3.1 Global OTC Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Drug Market Perspective (2019-2030)
2.2 OTC Drug Growth Trends by Region
2.2.1 Global OTC Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 OTC Drug Historic Market Size by Region (2019-2024)
2.2.3 OTC Drug Forecasted Market Size by Region (2025-2030)
2.3 OTC Drug Market Dynamics
2.3.1 OTC Drug Industry Trends
2.3.2 OTC Drug Market Drivers
2.3.3 OTC Drug Market Challenges
2.3.4 OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Drug Players by Revenue
3.1.1 Global Top OTC Drug Players by Revenue (2019-2024)
3.1.2 Global OTC Drug Revenue Market Share by Players (2019-2024)
3.2 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Drug Revenue
3.4 Global OTC Drug Market Concentration Ratio
3.4.1 Global OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2023
3.5 OTC Drug Key Players Head office and Area Served
3.6 Key Players OTC Drug Product Solution and Service
3.7 Date of Enter into OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Drug Breakdown Data by Type
4.1 Global OTC Drug Historic Market Size by Type (2019-2024)
4.2 Global OTC Drug Forecasted Market Size by Type (2025-2030)
5 OTC Drug Breakdown Data by Application
5.1 Global OTC Drug Historic Market Size by Application (2019-2024)
5.2 Global OTC Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America OTC Drug Market Size (2019-2030)
6.2 North America OTC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America OTC Drug Market Size by Country (2019-2024)
6.4 North America OTC Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Drug Market Size (2019-2030)
7.2 Europe OTC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe OTC Drug Market Size by Country (2019-2024)
7.4 Europe OTC Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Drug Market Size (2019-2030)
8.2 Asia-Pacific OTC Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific OTC Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific OTC Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Drug Market Size (2019-2030)
9.2 Latin America OTC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America OTC Drug Market Size by Country (2019-2024)
9.4 Latin America OTC Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Drug Market Size (2019-2030)
10.2 Middle East & Africa OTC Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa OTC Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa OTC Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Detail
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare OTC Drug Introduction
11.1.4 Bayer HealthCare Revenue in OTC Drug Business (2019-2024)
11.1.5 Bayer HealthCare Recent Development
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Detail
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) OTC Drug Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2019-2024)
11.2.5 GlaxoSmithKline(GSK) Recent Development
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Detail
11.3.2 Johnson&Johnson Business Overview
11.3.3 Johnson&Johnson OTC Drug Introduction
11.3.4 Johnson&Johnson Revenue in OTC Drug Business (2019-2024)
11.3.5 Johnson&Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer OTC Drug Introduction
11.4.4 Pfizer Revenue in OTC Drug Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi OTC Drug Introduction
11.5.4 Sanofi Revenue in OTC Drug Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca OTC Drug Introduction
11.6.4 AstraZeneca Revenue in OTC Drug Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 BioGaia
11.7.1 BioGaia Company Detail
11.7.2 BioGaia Business Overview
11.7.3 BioGaia OTC Drug Introduction
11.7.4 BioGaia Revenue in OTC Drug Business (2019-2024)
11.7.5 BioGaia Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Detail
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb OTC Drug Introduction
11.8.4 Bristol Myers Squibb Revenue in OTC Drug Business (2019-2024)
11.8.5 Bristol Myers Squibb Recent Development
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Detail
11.9.2 Bukwang Pharmaceutica Business Overview
11.9.3 Bukwang Pharmaceutica OTC Drug Introduction
11.9.4 Bukwang Pharmaceutica Revenue in OTC Drug Business (2019-2024)
11.9.5 Bukwang Pharmaceutica Recent Development
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Detail
11.10.2 Chr. Hansen Business Overview
11.10.3 Chr. Hansen OTC Drug Introduction
11.10.4 Chr. Hansen Revenue in OTC Drug Business (2019-2024)
11.10.5 Chr. Hansen Recent Development
11.11 Cipla
11.11.1 Cipla Company Detail
11.11.2 Cipla Business Overview
11.11.3 Cipla OTC Drug Introduction
11.11.4 Cipla Revenue in OTC Drug Business (2019-2024)
11.11.5 Cipla Recent Development
11.12 CoLucid
11.12.1 CoLucid Company Detail
11.12.2 CoLucid Business Overview
11.12.3 CoLucid OTC Drug Introduction
11.12.4 CoLucid Revenue in OTC Drug Business (2019-2024)
11.12.5 CoLucid Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Detail
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo OTC Drug Introduction
11.13.4 Daiichi Sankyo Revenue in OTC Drug Business (2019-2024)
11.13.5 Daiichi Sankyo Recent Development
11.14 Friggs
11.14.1 Friggs Company Detail
11.14.2 Friggs Business Overview
11.14.3 Friggs OTC Drug Introduction
11.14.4 Friggs Revenue in OTC Drug Business (2019-2024)
11.14.5 Friggs Recent Development
11.15 DSM
11.15.1 DSM Company Detail
11.15.2 DSM Business Overview
11.15.3 DSM OTC Drug Introduction
11.15.4 DSM Revenue in OTC Drug Business (2019-2024)
11.15.5 DSM Recent Development
11.16 Eisai
11.16.1 Eisai Company Detail
11.16.2 Eisai Business Overview
11.16.3 Eisai OTC Drug Introduction
11.16.4 Eisai Revenue in OTC Drug Business (2019-2024)
11.16.5 Eisai Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Detail
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly OTC Drug Introduction
11.17.4 Eli Lilly Revenue in OTC Drug Business (2019-2024)
11.17.5 Eli Lilly Recent Development
11.18 Herbalife
11.18.1 Herbalife Company Detail
11.18.2 Herbalife Business Overview
11.18.3 Herbalife OTC Drug Introduction
11.18.4 Herbalife Revenue in OTC Drug Business (2019-2024)
11.18.5 Herbalife Recent Development
11.19 Euradite
11.19.1 Euradite Company Detail
11.19.2 Euradite Business Overview
11.19.3 Euradite OTC Drug Introduction
11.19.4 Euradite Revenue in OTC Drug Business (2019-2024)
11.19.5 Euradite Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global OTC Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Class A OTC Drug
Table 3. Key Players of Class B OTC Drug
Table 4. Global OTC Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global OTC Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global OTC Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global OTC Drug Market Share by Region (2019-2024)
Table 8. Global OTC Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global OTC Drug Market Share by Region (2025-2030)
Table 10. OTC Drug Market Trends
Table 11. OTC Drug Market Drivers
Table 12. OTC Drug Market Challenges
Table 13. OTC Drug Market Restraints
Table 14. Global OTC Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global OTC Drug Market Share by Players (2019-2024)
Table 16. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2023)
Table 17. Ranking of Global Top OTC Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by OTC Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players OTC Drug Product Solution and Service
Table 21. Date of Enter into OTC Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global OTC Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global OTC Drug Revenue Market Share by Type (2019-2024)
Table 25. Global OTC Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global OTC Drug Revenue Market Share by Type (2025-2030)
Table 27. Global OTC Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global OTC Drug Revenue Market Share by Application (2019-2024)
Table 29. Global OTC Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global OTC Drug Revenue Market Share by Application (2025-2030)
Table 31. North America OTC Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America OTC Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America OTC Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe OTC Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe OTC Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe OTC Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific OTC Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific OTC Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific OTC Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America OTC Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America OTC Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa OTC Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa OTC Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa OTC Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bayer HealthCare Company Detail
Table 47. Bayer HealthCare Business Overview
Table 48. Bayer HealthCare OTC Drug Product
Table 49. Bayer HealthCare Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 50. Bayer HealthCare Recent Development
Table 51. GlaxoSmithKline(GSK) Company Detail
Table 52. GlaxoSmithKline(GSK) Business Overview
Table 53. GlaxoSmithKline(GSK) OTC Drug Product
Table 54. GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 55. GlaxoSmithKline(GSK) Recent Development
Table 56. Johnson&Johnson Company Detail
Table 57. Johnson&Johnson Business Overview
Table 58. Johnson&Johnson OTC Drug Product
Table 59. Johnson&Johnson Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 60. Johnson&Johnson Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer OTC Drug Product
Table 64. Pfizer Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi OTC Drug Product
Table 69. Sanofi Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca OTC Drug Product
Table 74. AstraZeneca Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. BioGaia Company Detail
Table 77. BioGaia Business Overview
Table 78. BioGaia OTC Drug Product
Table 79. BioGaia Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 80. BioGaia Recent Development
Table 81. Bristol Myers Squibb Company Detail
Table 82. Bristol Myers Squibb Business Overview
Table 83. Bristol Myers Squibb OTC Drug Product
Table 84. Bristol Myers Squibb Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 85. Bristol Myers Squibb Recent Development
Table 86. Bukwang Pharmaceutica Company Detail
Table 87. Bukwang Pharmaceutica Business Overview
Table 88. Bukwang Pharmaceutica OTC Drug Product
Table 89. Bukwang Pharmaceutica Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 90. Bukwang Pharmaceutica Recent Development
Table 91. Chr. Hansen Company Detail
Table 92. Chr. Hansen Business Overview
Table 93. Chr. Hansen OTC Drug Product
Table 94. Chr. Hansen Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 95. Chr. Hansen Recent Development
Table 96. Cipla Company Detail
Table 97. Cipla Business Overview
Table 98. Cipla OTC Drug Product
Table 99. Cipla Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 100. Cipla Recent Development
Table 101. CoLucid Company Detail
Table 102. CoLucid Business Overview
Table 103. CoLucid OTC Drug Product
Table 104. CoLucid Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 105. CoLucid Recent Development
Table 106. Daiichi Sankyo Company Detail
Table 107. Daiichi Sankyo Business Overview
Table 108. Daiichi Sankyo OTC Drug Product
Table 109. Daiichi Sankyo Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 110. Daiichi Sankyo Recent Development
Table 111. Friggs Company Detail
Table 112. Friggs Business Overview
Table 113. Friggs OTC Drug Product
Table 114. Friggs Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 115. Friggs Recent Development
Table 116. DSM Company Detail
Table 117. DSM Business Overview
Table 118. DSM OTC Drug Product
Table 119. DSM Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 120. DSM Recent Development
Table 121. Eisai Company Detail
Table 122. Eisai Business Overview
Table 123. Eisai OTC Drug Product
Table 124. Eisai Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 125. Eisai Recent Development
Table 126. Eli Lilly Company Detail
Table 127. Eli Lilly Business Overview
Table 128. Eli Lilly OTC Drug Product
Table 129. Eli Lilly Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 130. Eli Lilly Recent Development
Table 131. Herbalife Company Detail
Table 132. Herbalife Business Overview
Table 133. Herbalife OTC Drug Product
Table 134. Herbalife Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 135. Herbalife Recent Development
Table 136. Euradite Company Detail
Table 137. Euradite Business Overview
Table 138. Euradite OTC Drug Product
Table 139. Euradite Revenue in OTC Drug Business (2019-2024) & (US$ Million)
Table 140. Euradite Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global OTC Drug Market Share by Type: 2023 VS 2030
Figure 3. Class A OTC Drug Features
Figure 4. Class B OTC Drug Features
Figure 5. Global OTC Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global OTC Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Household Case Studies
Figure 10. OTC Drug Report Years Considered
Figure 11. Global OTC Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global OTC Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global OTC Drug Market Share by Region: 2023 VS 2030
Figure 14. Global OTC Drug Market Share by Players in 2023
Figure 15. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2023
Figure 17. North America OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America OTC Drug Market Share by Country (2019-2030)
Figure 19. United States OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe OTC Drug Market Share by Country (2019-2030)
Figure 23. Germany OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific OTC Drug Market Share by Region (2019-2030)
Figure 31. China OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America OTC Drug Market Share by Country (2019-2030)
Figure 39. Mexico OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa OTC Drug Market Share by Country (2019-2030)
Figure 43. Turkey OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia OTC Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bayer HealthCare Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 46. GlaxoSmithKline(GSK) Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 47. Johnson&Johnson Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 51. BioGaia Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 52. Bristol Myers Squibb Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 53. Bukwang Pharmaceutica Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 54. Chr. Hansen Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 55. Cipla Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 56. CoLucid Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 57. Daiichi Sankyo Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 58. Friggs Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 59. DSM Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 60. Eisai Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 61. Eli Lilly Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 62. Herbalife Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 63. Euradite Revenue Growth Rate in OTC Drug Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs